Works matching DE "MITOXANTRONE hydrochloride"

Results: 177

Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.

Published in:

Veterinary & Comparative Oncology, 2010, v. 8, n. 1, p. 11, doi. 10.1111/j.1476-5829.2009.00199.x

By:

Daters, A. T.;
Mauldin, G. E.;
Mauldin, G. N.;
Brodsky, E. M.;
Post, G. S.

Publication type:

Article

Postoperative radiotherapy and mitoxantrone for anal sac adenocarcinoma in the dog: 15 cases (1991–2001).

Published in:

Veterinary & Comparative Oncology, 2003, v. 1, n. 2, p. 94, doi. 10.1046/j.1476-5829.2003.00013.x

By:

Turek, M. M.;
Forrest, L. J.;
Adams, W. M.;
Helfand, S. C.;
Vail, D. M.

Publication type:

Article

Biodegradation and Toxicity of the Antineoplastics Mitoxantron Hydrochloride and Treosulfane in the Closed Bottle Test (OECD 301 D).

Published in:

Bulletin of Environmental Contamination & Toxicology, 1997, v. 58, n. 5, p. 704, doi. 10.1007/s001289900390

By:

Al-Ahmad, A.;
Kümmerer, K.;
Schön, G.

Publication type:

Article

Preliminary Investigation of Mitoxantrone Coating on Stent-Grafts to Inhibit Neointimal Proliferation.

Published in:

Journal of Endovascular Therapy, 2005, v. 12, n. 4, p. 479, doi. 10.1583/04-1444MR.1

By:

Dirsch, Olaf;
Dahmen, Uta;
Gu, Yan L.;
Yuan Ji;
Karoussos, Ira A.;
Wieneke, Heinrich;
Erbel, Raimund

Publication type:

Article

Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases.

Published in:

Journal of Gastroenterology, 2004, v. 39, n. 4, p. 362, doi. 10.1007/s00535-003-1303-8

By:

Yang, Tsai-Shen;
Chang, Hsien-Khun;
Chen, Jen-Shi;
Lin, Yung-Chang;
Liau, Chi-Ting;
Chang, Wen-Cheng

Publication type:

Article

Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 6, p. 1014, doi. 10.1038/bmt.2009.305

By:

Tappenden, P.;
Saccardi, R.;
Confavreux, C.;
Sharrack, B.;
Muraro, P. A.;
Mancardi, G. L.;
Kozak, T.;
Farge-Bancel, D.;
Madan, J.;
Rafia, R.;
Akehurst, R.;
Snowden, J.

Publication type:

Article

Long-Term Risk of Leukaemia or Cardiomyopathy after Mitoxantrone Therapy for Multiple Sclerosis.

Published in:

European Neurology, 2012, v. 67, n. 1, p. 45, doi. 10.1159/000334101

By:

Mulroy, Eoin;
Joyce, Emer;
Scott, Jaqueline;
Melling, Jane;
Goggin, Carole;
Mahon, Niall;
O'Rourke, Killian;
Lynch, Timothy

Publication type:

Article

Tolerability and Acceptance of Prolonged Low/Delayed Mitoxantrone Regimens in Patients with Worsening Multiple Sclerosis.

Published in:

European Neurology, 2011, v. 65, n. 1, p. 40, doi. 10.1159/000323013

By:

Zecca, Chiara;
Petrini, Liliane;
Limoni, Costanzo;
Staedler, Claudio;
Gobbi, Claudio

Publication type:

Article

Assessment of Potential Cardiotoxic Side Effects of Mitoxantrone in Patients with Multiple Sclerosis.

Published in:

European Neurology, 2005, v. 54, n. 1, p. 28, doi. 10.1159/000087242

By:

Zingler, Vera Carina;
Näbauer, Michael;
Jahn, Klaus;
Groß, Ariane;
Hohlfeld, Reinhard;
Brandt, Thomas;
Strupp, Michael

Publication type:

Article

Effects of Mitoxantrone on Multiple Sclerosis Patients’ Lymphocyte Subpopulations and Production of Immunoglobulin, TNF-alpha and IL-10.

Published in:

European Neurology, 2003, v. 49, n. 3, p. 137, doi. 10.1159/000069082

By:

Gbadamosi, Joystone;
Buhmann, Carsten;
Tessmer, Wiebke;
Moench, Andrea;
Haag, Friedrich;
Heesen, Christoph

Publication type:

Article

Efficacy of natalizumab in multiple sclerosis patients with high disease activity: a Danish nationwide study.

Published in:

European Journal of Neurology, 2009, v. 16, n. 3, p. 420, doi. 10.1111/j.1468-1331.2008.02517.x

By:

Oturai, A. B.;
Koch-Henriksen, N.;
Petersen, T.;
Jensen, P. E. H.;
Sellebjerg, F.;
Sorensen, P. S.

Publication type:

Article

Therapeutic outcome 3 years after switching of immunomodulatory therapies in patients with relapsing–remitting multiple sclerosis in Argentina.

Published in:

European Journal of Neurology, 2008, v. 15, n. 4, p. 386, doi. 10.1111/j.1468-1331.2008.02071.x

By:

Carrá, A.;
Onaha, P.;
Luetic, G.;
Burgos, M.;
Crespo, E.;
Deri, N.;
Halfon, M.;
Jaacks, G.;
López, A.;
Sinay, V.;
Vrech, C.

Publication type:

Article

A recommended treatment algorithm in relapsing multiple sclerosis: report of an international consensus meeting.

Published in:

European Journal of Neurology, 2006, v. 13, n. 1, p. 61, doi. 10.1111/j.1468-1331.2006.01147.x

By:

Karussis, D.;
Biermann, L. D.;
Bohlega, S.;
Boiko, A.;
Chofflon, M.;
Fazekas, F.;
Freedman, M.;
Gebeily, S.;
Gouider, R.;
Havrdova, E.;
Jakab, G.;
Karabudak, R.;
Miller, A.

Publication type:

Article

Efficacy and toxicity of mitoxantrone and oral etoposide in the treatment of hormone-refractory prostate cancer: pilot study.

Published in:

Einstein (16794508), 2010, v. 8, n. 3, p. 336, doi. 10.1590/s1679-45082010ao1622

By:

Kaliks, Rafael;
Guerra, Camila;
Del Giglio, Auro

Publication type:

Article

Mitoxantrone slowed progression of disability and reduced relapses in multiple sclerosis.

Published in:

ACP Journal Club, 2003, v. 139, n. 2, p. 45, doi. 10.7326/acpjc-2003-139-2-045

By:

Murray, T. Jock

Publication type:

Article

Sequential maintenance treatment with glatiramer acetate after mitoxantrone is safe and can limit exposure to immunosuppression in very active, relapsing remitting multiple sclerosis.

Published in:

Journal of Neurology, 2006, v. 253, n. 9, p. 1160, doi. 10.1007/s00415-006-0178-z

By:

Ramtahal, Jason;
Jacob, Anu;
Das, Kumar;
Boggild, Mike

Publication type:

Article

Journal Club.

Published in:

Journal of Neurology, 2002, v. 249, n. 11, p. 1620

By:

Strupp, Michael

Publication type:

Article

Advanced PCa agent prolongs progression-free survival.

Published in:

Urology Times, 2011, v. 39, n. 5, p. 10

By:

Gebhart, Fred

Publication type:

Article

Efficacy of new advanced PCa treatment affirmed.

Published in:

Urology Times, 2010, v. 38, n. 10, p. 6

By:

Krader, Cheryl Guttman;
SARTOR, OLIVER

Publication type:

Article

Chemo regimen called 'new standard' in advanced PCa.

Published in:

Urology Times, 2004, v. 32, n. 10, p. 1

By:

Bankhead, Charles

Publication type:

Article

Drug relieves pain from hormone-refractory PCa.

Published in:: Urology Times, 1997, v. 25, n. 4, p. 61
Publication type:: Article

Mitoxantrone helps decrease pain of PCa.

Published in:: Urology Times, 1996, v. 24, n. 10, p. 40
Publication type:: Article

Exposure of CD34 precursors to cytostatic anthraquinone-derivatives induces rapid dendritic cell differentiation: implications for cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 2, p. 181, doi. 10.1007/s00262-011-1039-x

By:

Ven, Rieneke;
Reurs, Anneke;
Wijnands, Pepijn;
Wetering, Sandra;
Kruisbeek, Ada;
Hooijberg, Erik;
Scheffer, George;
Scheper, Rik;
Gruijl, Tanja

Publication type:

Article

Pharmacovigilance, cancer et médicaments anticancéreux.

Published in:

Oncologie (Tech Science Press), 2004, v. 6, n. 1, p. 66, doi. 10.1007/s10269-004-0018-7

By:

Apretna, E.;
Thiessard, F.;
Miremont-Salamé, G.;
Haramburu, F.

Publication type:

Article

Recurrent neutrophilic eccrine hidradenitis.

Published in:

British Journal of Dermatology, 1992, v. 127, n. 5, p. 529, doi. 10.1111/j.1365-2133.1992.tb14854.x

By:

Bernstein, E. F.;
Spielvogelj, R. L.;
Topolsky:, D. L.

Publication type:

Article

Comparative study of mitoxantrone efficacy profile in patients with relapsing—remitting and secondary progressive multiple sclerosis.

Published in:

Multiple Sclerosis (13524585), 2010, v. 16, n. 12, p. 1490, doi. 10.1177/1352458510379613

By:

Esposito, Federica;
Radaelli, Marta;
Martinelli, Vittorio;
Sormani, Maria Pia;
Martinelli Boneschi, Filippo;
Moiola, Lucia;
Rocca, Maria Assunta;
Rodegher, Mariaemma;
Comi, Giancarlo

Publication type:

Article

Dose-dependent melanonychia by mitoxantrone.

Published in:

2009

By:

Reinsberger, C.;
Meuth, S. G.;
Wiendl, H.

Publication type:

Case Study

Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it?

Published in:

Multiple Sclerosis (13524585), 2009, v. 15, n. 4, p. 505, doi. 10.1177/1352458508100967

By:

Ellis, R.;
Boggild, M.

Publication type:

Article

Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis.

Published in:

Multiple Sclerosis (13524585), 2008, v. 14, n. 5, p. 663, doi. 10.1177/1352458507085759

By:

Vollmer, T.;
Panitch, H.;
Bar-Or, A.;
Dunn, J.;
Freedman, M. S.;
Gazda, S. K.;
Campagnolo, D.;
Deutsch, F.;
Arnold, D. L.

Publication type:

Article

Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome.

Published in:

Multiple Sclerosis (13524585), 2008, v. 14, n. 2, p. 278, doi. 10.1177/1352458507082604

By:

Kimiskidis, V. K.;
Sakellari, I.;
Tsimourtou, V.;
Kapina, V.;
Papagiannopoulos, S.;
Kazis, D.;
Vlaikidis, N.;
Anagnostopoulos, A.;
Fassas, A.

Publication type:

Article

Chronic myeloid leukemia associated with mitoxantrone treatment in a patient with MS.

Published in:

Multiple Sclerosis (13524585), 2008, v. 14, n. 2, p. 272, doi. 10.1177/1352458507082941

By:

Sadiq, Saud A.;
Rammal, Mustapha;
Sara, Gabriel

Publication type:

Article

Immunosuppression.

Published in:: 2007
Publication type:: Abstract

Mitoxantrone treatment in patients with early relapsing-remitting multiple sclerosis.

Published in:

Multiple Sclerosis (13524585), 2007, v. 13, n. 8, p. 975, doi. 10.1177/1352458507077621

By:

Cocco, E.;
Marchi, P.;
Sardu, C.;
Russo, P.;
Paolillo, A.;
Mascia, M. G.;
Solla, M.;
Frau, J.;
Lorefice, L.;
Massole, S.;
Floris, G.;
Marrosu, M. G.

Publication type:

Article

Clinical follow-up of 304 patients with multiple sclerosis three years after mitoxantrone treatment.

Published in:

Multiple Sclerosis (13524585), 2007, v. 13, n. 5, p. 626, doi. 10.1177/1352458506072543

By:

Debouverie, M.;
Taillandier, L.;
Pittion-Vouyovitch, S.;
Louis, S.;
Vespignani, H.

Publication type:

Article

Predictive parameters of mitoxantrone effectiveness in the treatment of multiple sclerosis.

Published in:

Multiple Sclerosis (13524585), 2004, v. 10, n. 4, p. 407, doi. 10.1191/1352458504ms1066oa

By:

Debouverie, M.;
Vandenberghe, N.;
Morrissey, S. P.;
Anxionnat, R.;
Pittion-Vouyovitch, S.;
Vespignani, H.;
Edan, G.

Publication type:

Article

Mitoxantrone therapy in multiple sclerosis and acute leukaemia: a case report out of 644 treated patients.

Published in:

Multiple Sclerosis (13524585), 2004, v. 10, n. 4, p. 472, doi. 10.1191/1352458504ms1047cr

By:

Raymond Voltz;
Starck, Michaela;
Zingler, Vera;
Strupp, Michael;
Kolb, Hans-Jochem

Publication type:

Article

Mitoxantrone as a potential therapy for primary progressive multiple sclerosis.

Published in:

Multiple Sclerosis (13524585), 2004, v. 10, p. 58, doi. 10.1191/1352458504ms1032oa

By:

Stüve, Olaf;
Kita, Mariko;
Pelletier, Daniel;
Fox, Robert J.;
Stone, Jerome;
Goodkin, Donald E.;
Zamvil, Scott S.

Publication type:

Article

Therapy-related leukemia in mitozantrone treated patients.

Published in:

Multiple Sclerosis (13524585), 2003, v. 9, n. 4, p. 426, doi. 10.1191/1352458503ms898xx

By:

Goodkin, Donald E

Publication type:

Article

Letters to the Editor.

Published in:: Multiple Sclerosis (13524585), 2003, v. 9, n. 2, p. 213, doi. 10.1191/1352458503ms891xx
Publication type:: Article

Rapid onset Mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis.

Published in:

Multiple Sclerosis (13524585), 2003, v. 9, n. 1, p. 59, doi. 10.1191/1352458503ms896oa

By:

Avasarala, Jagannadha R;
Cross, Anne H;
Clifford, David B;
Singer, Barry A;
Siegel, Barry A;
Abbey, Elliot E

Publication type:

Article

A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis.

Published in:

Multiple Sclerosis (13524585), 2002, v. 8, n. 5, p. 441, doi. 10.1191/1352458502ms836oa

By:

Ghalie, RG;
Mauch, E;
Edan, G;
Hartung, HP;
Gonsette, RE;
Eisenmann, S;
Le Page, E;
Butine, MD;
Goodkin, DE

Publication type:

Article

Results of an international questionnaire on immunosuppressive treatment of multiple sclerosis.

Published in:

Multiple Sclerosis (13524585), 2002, v. 8, n. 2, p. 139, doi. 10.1191/1352458502ms791oa

By:

Hommes, OR;
Weiner, HL

Publication type:

Article

Immunosuppression/Immune-Reconstitution.

Published in:: 1999
Publication type:: Abstract

Is there a role of intensive immunosuppression in multiple sclerosis?

Published in:: 1999
Publication type:: Abstract

Immunosuppression/Immune-Reconstitution.

Published in:: Multiple Sclerosis (13524585), 1999, v. 5, n. 1, p. S94
Publication type:: Article

Mitoxantrone: a review of its use in multiple sclerosis.

Published in:

2004

By:

Scott, Lesley J.;
Figgitt, David P.

Publication type:

journal article

Prognostic features for response and survival in elderly patients with de novo acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabine.

Published in:

Leukemia & Lymphoma, 2005, v. 46, n. 3, p. 367, doi. 10.1080/10428190400013076

By:

Grigg, A. P.;
Reynolds, J.;
McQuillan, A.;
Juneja, S. K.;
di Iulio, J.;
Hui, C.;
Smith, C.;
Kimber, R.;
Bradstock, K. F.

Publication type:

Article

Bendamustine/Mitoxantrone/Rituximab (BMR): A Very Effective, Well Tolerated Outpatient Chemoimmunotherapy for Relapsed and Refractory CD20-positive Indolent Malignancies. Final Results of a Pilot Study.

Published in:

Leukemia & Lymphoma, 2004, v. 45, n. 12, p. 2445, doi. 10.1080/10428190400004521

By:

Weide, Rudolf;
Pandorf, Annette;
Heymanns, Jochen;
Köppler, Hubert

Publication type:

Article

High Dose Chemotherapy with Thiotepa, Mitoxantrone and Carboplatin (TMJ) Followed by Autologous Stem Cell Support in 100 Consecutive Lymphoma Patients in a Single Centre: Analysis of Efficacy, Toxicity and Prognostic Factors.

Published in:

Leukemia & Lymphoma, 2004, v. 45, n. 11, p. 2253, doi. 10.1080/10428190410001723250

By:

Waheed, F.;
Kancherla, R.;
Seiter, K.;
Liu, D.;
Qureshi, Z.;
Hoang, A.;
Ahmed, T.

Publication type:

Article

A Randomized Trial Comparing Intensified CNOP vs. CHOP in Patients with Aggressive Non-Hodgkin's Lymphoma.

Published in:

Leukemia & Lymphoma, 2003, v. 44, n. 4, p. 635, doi. 10.1080/1042819031000063471

By:

Pangalis, Gerassimos A.;
Vassikopoulos, Theodoros P.;
Michalis, Evridiki;
Roussou, Paraskevi;
Vrakidou, Effimia;
Repousis, Panayiotis;
Angelopoulou, Maria K.;
Siakantaris, Marina P.;
Korantzis, John;
Symeonidis, Argyrios;
Grigorakis, Vassiliki;
Stefanoudakis, Ekaterini;
Stamatllou, Marina;
Bourantas, Konstantinos L.;
Kalmantis, Themis;
Christopoulos, George;
Kokkinis, Garyfallia;
Mihalakeas, Ilias;
Papayiannis, Antonios

Publication type:

Article